Original Research
Accepted on 09 Feb 2026
Real-world effectiveness and safety of Sacituzumab Govitecan in metastatic triple-negative breast cancer: Results from the multicenter retrospective observational SACISUR cohort in Southern Spain
in Breast Cancer